4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-022792
Director acquired 330,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MATLIN DAVID J Director | 2025-07-31 | Conversion | +330,000 | 1,271,944 | D | ||
| Derivatives | |||||||
| MATLIN DAVID J Director | 2025-07-31 | Conversion · Series A Preferred Stock | −100,000 | 0 | D | ||
Loading xslF345X06/wk-form4_1775074153.xml…